Belviq: the New FDA Approved Obesity-Fighting Drug

Belviq: the New FDA Approved Obesity-Fighting Drug Play

Jan.14 (Bloomberg) –- Arena Pharmaceuticals President & CEO Jack Lief and Eisai President & CEO Lonnel Coats discuss the new obesity-fighting drug, Belviq, how it works and the potential side effects with Mark Crumpton on Bloomberg Television's "Taking Stock." (Source: Bloomberg)

  • On Air Now

    The Pulse Watch Now

  • Next

    Bloomberg Surveillance

blog comments powered by Disqus